GN CEO takes aim at the number two spot in the US
GN Resound has its sight set on the number two spot in the important Veterans Affairs segment in the US with the launch of a new hearing device. CEO Anders Hedegaard denies speculation that the group has lost focus due to a number of recent public disputes.
BY LONNI LYNGE
For the 21st quarter running, GN Store Nord’s hearing device unit, GN Resound, has managed to capture market shares, and the satisfaction is evident in the voice of CEO Anders Hedegaard as MedWatch catches him on the phone following the publication of the company’s Q3 report.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Rivals breathe down GN’s neck with wireless technology
For abonnenter
GN Resound strikes deal with Cochlear
For abonnenter
GN continues progress in the US
For abonnenter
